| (Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of principal executive offices and Zip Code) | ||
( | ||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) Exhibits. | |||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| MICRON TECHNOLOGY, INC. | |||||||||||
| Date: | By: | /s/ Mark Murphy | |||||||||
| Name: | Mark Murphy | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Contacts: | Satya Kumar | Erica Rodriguez Pompen | ||||||
| Investor Relations | Media Relations | |||||||
| [email protected] | ||||||||
(408) 450-6199 | (408) 834-1873 | |||||||
| Quarterly Financial Results | |||||||||||||||||||||||
| (in millions, except per share amounts) | GAAP(1) | Non-GAAP(2) | |||||||||||||||||||||
FQ1-24 | FQ4-23 | FQ1-23 | FQ1-24 | FQ4-23 | FQ1-23 | ||||||||||||||||||
| Revenue | $ | 4,726 | $ | 4,010 | $ | 4,085 | $ | 4,726 | $ | 4,010 | $ | 4,085 | |||||||||||
| Gross margin | (35) | (435) | 893 | 37 | (366) | 934 | |||||||||||||||||
| percent of revenue | (0.7 | %) | (10.8 | %) | 21.9 | % | 0.8 | % | (9.1 | %) | 22.9 | % | |||||||||||
| Operating expenses | 1,093 | 1,037 | 1,102 | 992 | 842 | 999 | |||||||||||||||||
| Operating income (loss) | (1,128) | (1,472) | (209) | (955) | (1,208) | (65) | |||||||||||||||||
| percent of revenue | (23.9 | %) | (36.7 | %) | (5.1 | %) | (20.2 | %) | (30.1 | %) | (1.6 | %) | |||||||||||
| Net income (loss) | (1,234) | (1,430) | (195) | (1,048) | (1,177) | (39) | |||||||||||||||||
| Diluted earnings (loss) per share | (1.12) | (1.31) | (0.18) | (0.95) | (1.07) | (0.04) | |||||||||||||||||
FQ2-24 | GAAP(1) Outlook | Non-GAAP(2) Outlook | ||||||
Revenue | $5.30 billion ± $200 million | $5.30 billion ± $200 million | ||||||
Gross margin | 12.0% ± 1.5% | 13.0% ± 1.5% | ||||||
Operating expenses | $1.07 billion ± $15 million | $950 million ± $15 million | ||||||
Diluted earnings (loss) per share | ($0.45) ± $0.07 | ($0.28) ± $0.07 | ||||||
1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| November 30, 2023 | August 31, 2023 | December 1, 2022 | |||||||||
| Revenue | $ | 4,726 | $ | 4,010 | $ | 4,085 | |||||
| Cost of goods sold | 4,761 | 4,445 | 3,192 | ||||||||
| Gross margin | (35) | (435) | 893 | ||||||||
| Research and development | 845 | 719 | 849 | ||||||||
| Selling, general, and administrative | 263 | 219 | 251 | ||||||||
| Restructure and asset impairments | — | 4 | 13 | ||||||||
| Other operating (income) expense, net | (15) | 95 | (11) | ||||||||
| Operating income (loss) | (1,128) | (1,472) | (209) | ||||||||
| Interest income | 132 | 134 | 88 | ||||||||
| Interest expense | (132) | (129) | (51) | ||||||||
| Other non-operating income (expense), net | (27) | 9 | (4) | ||||||||
| (1,155) | (1,458) | (176) | |||||||||
| Income tax (provision) benefit | (73) | 24 | (8) | ||||||||
| Equity in net income (loss) of equity method investees | (6) | 4 | (11) | ||||||||
| Net income (loss) | $ | (1,234) | $ | (1,430) | $ | (195) | |||||
| Earnings (loss) per share | |||||||||||
| Basic | $ | (1.12) | $ | (1.31) | $ | (0.18) | |||||
| Diluted | (1.12) | (1.31) | (0.18) | ||||||||
| Number of shares used in per share calculations | |||||||||||
| Basic | 1,100 | 1,095 | 1,090 | ||||||||
| Diluted | 1,100 | 1,095 | 1,090 | ||||||||
| As of | November 30, 2023 | August 31, 2023 | ||||||
| Assets | ||||||||
| Cash and equivalents | $ | 8,075 | $ | 8,577 | ||||
| Short-term investments | 973 | 1,017 | ||||||
| Receivables | 2,943 | 2,443 | ||||||
| Inventories | 8,276 | 8,387 | ||||||
| Other current assets | 791 | 820 | ||||||
| Total current assets | 21,058 | 21,244 | ||||||
| Long-term marketable investments | 720 | 844 | ||||||
| Property, plant, and equipment | 37,677 | 37,928 | ||||||
| Operating lease right-of-use assets | 648 | 666 | ||||||
| Intangible assets | 416 | 404 | ||||||
| Deferred tax assets | 781 | 756 | ||||||
| Goodwill | 1,150 | 1,150 | ||||||
| Other noncurrent assets | 1,326 | 1,262 | ||||||
| Total assets | $ | 63,776 | $ | 64,254 | ||||
| Liabilities and equity | ||||||||
| Accounts payable and accrued expenses | $ | 3,946 | $ | 3,958 | ||||
| Current debt | 908 | 278 | ||||||
| Other current liabilities | 1,108 | 529 | ||||||
| Total current liabilities | 5,962 | 4,765 | ||||||
| Long-term debt | 12,597 | 13,052 | ||||||
| Noncurrent operating lease liabilities | 601 | 603 | ||||||
| Noncurrent unearned government incentives | 705 | 727 | ||||||
| Other noncurrent liabilities | 1,026 | 987 | ||||||
| Total liabilities | 20,891 | 20,134 | ||||||
| Commitments and contingencies | ||||||||
| Shareholders’ equity | ||||||||
| Common stock | 124 | 124 | ||||||
| Additional capital | 11,217 | 11,036 | ||||||
| Retained earnings | 39,356 | 40,824 | ||||||
| Treasury stock | (7,552) | (7,552) | ||||||
| Accumulated other comprehensive income (loss) | (260) | (312) | ||||||
| Total equity | 42,885 | 44,120 | ||||||
| Total liabilities and equity | $ | 63,776 | $ | 64,254 | ||||
| Three months ended | November 30, 2023 | December 1, 2022 | ||||||
| Cash flows from operating activities | ||||||||
| Net income (loss) | $ | (1,234) | $ | (195) | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation expense and amortization of intangible assets | 1,915 | 1,921 | ||||||
| Stock-based compensation | 188 | 146 | ||||||
Change in operating assets and liabilities: | ||||||||
| Receivables | (501) | 1,842 | ||||||
| Inventories | 111 | (1,697) | ||||||
| Accounts payable and accrued expenses | 271 | (630) | ||||||
Other current liabilities | 579 | (430) | ||||||
| Other | 72 | (14) | ||||||
| Net cash provided by operating activities | 1,401 | 943 | ||||||
| Cash flows from investing activities | ||||||||
| Expenditures for property, plant, and equipment | (1,796) | (2,449) | ||||||
| Purchases of available-for-sale securities | (199) | (90) | ||||||
Proceeds from maturities and sales of available-for-sale securities | 374 | 362 | ||||||
| Proceeds from government incentives | 85 | 2 | ||||||
| Other | (22) | (91) | ||||||
| Net cash provided by (used for) investing activities | (1,558) | (2,266) | ||||||
| Cash flows from financing activities | ||||||||
| Payments of dividends to shareholders | (129) | (126) | ||||||
| Payments on equipment purchase contracts | (56) | (47) | ||||||
| Repayments of debt | (53) | (20) | ||||||
| Repurchases of common stock - repurchase program | — | (425) | ||||||
| Proceeds from issuance of debt | — | 3,349 | ||||||
| Other | (114) | (99) | ||||||
| Net cash provided by (used for) financing activities | (352) | 2,632 | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | (1) | (6) | ||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | (510) | 1,303 | ||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 8,656 | 8,339 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 8,146 | $ | 9,642 | ||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| November 30, 2023 | August 31, 2023 | December 1, 2022 | |||||||||
| Provision to write down inventory to NRV | $ | — | $ | — | $ | — | |||||
| Lower costs from sale of inventory written down in prior periods | 605 | 563 | — | ||||||||
| $ | 605 | $ | 563 | $ | — | ||||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| November 30, 2023 | August 31, 2023 | December 1, 2022 | |||||||||
| GAAP gross margin | $ | (35) | $ | (435) | $ | 893 | |||||
| Stock-based compensation | 67 | 64 | 36 | ||||||||
| Other | 5 | 5 | 5 | ||||||||
| Non-GAAP gross margin | $ | 37 | $ | (366) | $ | 934 | |||||
| GAAP operating expenses | $ | 1,093 | $ | 1,037 | $ | 1,102 | |||||
| Stock-based compensation | (115) | (87) | (90) | ||||||||
| Restructure and asset impairments | — | (4) | (13) | ||||||||
Goodwill impairment | — | (101) | — | ||||||||
| Other | 14 | (3) | — | ||||||||
| Non-GAAP operating expenses | $ | 992 | $ | 842 | $ | 999 | |||||
| GAAP operating income (loss) | $ | (1,128) | $ | (1,472) | $ | (209) | |||||
| Stock-based compensation | 182 | 151 | 126 | ||||||||
| Restructure and asset impairments | — | 4 | 13 | ||||||||
Goodwill impairment | — | 101 | — | ||||||||
| Other | (9) | 8 | 5 | ||||||||
| Non-GAAP operating income (loss) | $ | (955) | $ | (1,208) | $ | (65) | |||||
GAAP net income (loss) | $ | (1,234) | $ | (1,430) | $ | (195) | |||||
| Stock-based compensation | 182 | 151 | 126 | ||||||||
| Restructure and asset impairments | — | 4 | 13 | ||||||||
Goodwill impairment | — | 101 | — | ||||||||
| Other | (10) | 7 | 10 | ||||||||
Estimated tax effects of above and other tax adjustments | 14 | (10) | 7 | ||||||||
| Non-GAAP net income (loss) | $ | (1,048) | $ | (1,177) | $ | (39) | |||||
GAAP diluted earnings (loss) per share | $ | (1.12) | $ | (1.31) | $ | (0.18) | |||||
Effects of the above adjustments | 0.17 | 0.24 | 0.14 | ||||||||
Non-GAAP diluted earnings (loss) per share | $ | (0.95) | $ | (1.07) | $ | (0.04) | |||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| November 30, 2023 | August 31, 2023 | December 1, 2022 | |||||||||
GAAP net cash provided by operating activities | $ | 1,401 | $ | 249 | $ | 943 | |||||
Expenditures for property, plant, and equipment | (1,796) | (1,461) | (2,449) | ||||||||
Payments on equipment purchase contracts | (56) | (26) | (47) | ||||||||
| Proceeds from sales of property, plant, and equipment | 33 | 18 | 23 | ||||||||
Proceeds from government incentives | 85 | 462 | 2 | ||||||||
| Investments in capital expenditures, net | (1,734) | (1,007) | (2,471) | ||||||||
Adjusted free cash flow | $ | (333) | $ | (758) | $ | (1,528) | |||||
FQ2-24 | GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||||
Revenue | $5.30 billion ± $200 million | — | $5.30 billion ± $200 million | ||||||||||||||||||||
Gross margin | 12.0% ± 1.5% | 1.0% | A | 13.0% ± 1.5% | |||||||||||||||||||
Operating expenses | $1.07 billion ± $15 million | $122 million | B | $950 million ± $15 million | |||||||||||||||||||
Diluted earnings (loss) per share(1) | ($0.45) ± $0.07 | $0.17 | A, B, C | ($0.28) ± $0.07 | |||||||||||||||||||
Non-GAAP Adjustments (in millions) | |||||||||||||||||||||||
A | Stock-based compensation – cost of goods sold | $ | 75 | ||||||||||||||||||||
A | Other – cost of goods sold | 4 | |||||||||||||||||||||
B | Stock-based compensation – research and development | 77 | |||||||||||||||||||||
B | Stock-based compensation – sales, general, and administrative | 45 | |||||||||||||||||||||
C | Tax effects of the above items and other tax adjustments | (13) | |||||||||||||||||||||
| $ | 188 | ||||||||||||||||||||||